Results 41 to 50 of about 857,361 (295)

Comparative analysis of environmental persistence of SARS-CoV-2 variants and seasonal coronaviruses

open access: yesApplied and Environmental Microbiology
Conducting persistence studies of infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on environmental surfaces may require a biosafety level 3 (BSL-3) laboratory. We aimed to compare the environmental persistence of BSL-2 level human
Geun Woo Park   +10 more
doaj   +1 more source

Remdesivir for the Treatment of COVID-19: A Systematic Review of the Literature [PDF]

open access: yes, 2020
In March 2020, the World Health Organization declared the spread of SARS-CoV-2 a global pandemic. To date, coronavirus disease-2019 (COVID-19) has spread to over 200 countries, leading to over 1.6 million cases and over 99,000 deaths. Given that there is
Aly, Besma   +9 more
core  

Coronavirus Disease 2019 and Cardiac Arrhythmias

open access: yesEuropean Cardiology Review, 2020
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a very contagious virus, has led to the coronavirus disease 2019 (COVID-19) pandemic.
Antoni Martínez-Rubio   +3 more
doaj   +1 more source

Levels of feline infectious peritonitis virus in blood, effusions, and various tissues and the role of lymphopenia in disease outcome following experimental infection. [PDF]

open access: yes, 2015
Twenty specific pathogen free cats were experimentally infected with a virulent cat-passaged type I field strain of FIPV. Eighteen cats succumbed within 2-4 weeks to effusive abdominal FIP, one survived for 6 weeks, and one seroconverted without outward ...
Eckstrand, Chrissy   +4 more
core   +2 more sources

Association of infection-induced antibody levels with risk of subsequent SARS–COV-2 reinfection among healthcare professionals, Rhode Island, 1 March 2020–17 February 2021

open access: yesMicrobiology Spectrum
Numerous studies have investigated vaccine-induced correlates of protection (CoP) against severe acute respiratory syndrome–coronavirus 2 (SARS–CoV-2) infection, but data on infection-induced CoP are limited.
Jianrong Shi   +9 more
doaj   +1 more source

Coronavirus Disease 2019-Associated Coagulopathy

open access: yesMicroorganisms, 2022
Coronavirus disease 2019 (COVID-19)-associated coagulopathy is an acute illness characterized by thrombosis with or without hemorrhage after COVID-19 infection.
Jun-Won Seo   +3 more
doaj   +1 more source

Seroprevalence of SARS-CoV-2 IgG antibodies in children seeking medical care in Seattle, WA June 2020 to December 2022

open access: yesMicrobiology Spectrum
Seroprevalence studies play an important role in estimating the number of children infected with SARS-CoV-2. We report SARS-CoV-2 seroprevalence in children seeking medical care for any reason at a free-standing pediatric hospital in Seattle, WA over a 2.
Amanda L. Adler   +9 more
doaj   +1 more source

Coronavirus disease COVID-2019

open access: yesБезопасность и риск фармакотерапии, 2020
The paper presents data on the coronavirus diseaseCOVID-2019 caused by the SARS-CoV-2 coronavirus, which was temporarily named 2019-nCoV (2019 novel coronavirus) until 11 February 2020.
B. K. Romanov
doaj   +1 more source

Identification of individuals with gonorrhoea within sexual networks: a population-based study.

open access: yes, 2006
BACKGROUND: Molecular typing of Neisseria gonorrhoeae and contact tracing provide a combined approach for analysis of sexual networks in metropolitan areas, although there are some difficulties in application.
Bishop, Cynthia J   +7 more
core   +1 more source

Middle East respiratory syndrome coronavirus: current situation and travel-associated concerns [PDF]

open access: yes, 2016
This article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source.
Al-Tawfiq, Jaffar A.   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy